Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
EM Systems Co., Ltd. (4820.T)
JPY510.00
+5.00 (+0.99%)
JP JPX Healthcare Medical - Healthcare Information Services
Address
Shin-Osaka Brick Building 532-0003
Osaka, JP
Osaka, JP
CEO
Hiromasa Kunimitsu
Website
emsystems.co.jp
IPO
2003-05-02
ISIN JP3130200003
Description
EM Systems Co., Ltd. is a Japanese company that specializes in providing a comprehensive suite of IT solutions designed for pharmacies, medical clinics, and social welfare/care facilities. Its product portfolio for pharmacies encompasses systems for medical fee receipt processing and electronic medication records. For clinics, the company supplies medical accounting and electronic patient record systems. Additionally, EM Systems develops administrative processing systems specifically tailored for care and welfare service providers. The company was established in 1980 and is based in Osaka, Japan.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
JPY510.00
+5.00 (+0.99%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
142.9K
Beta
0.52
Float Shares
29.24M
Free Float %
42.2%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.47% | -18.66% | -21.52% | -24.19% | -33.83% | -31.11% | -26.27% | -32.32% | -35.73% | +74.88% | +471.73% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
510.00
DCF (Unlevered)
1,498.66
+193.9%
DCF (Levered)
738.89
+44.9%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
5.31
Safe zone
Piotroski F-Score
3 / 9
Average
MOAT Score
4 / 10
Developing
Composite Rating
A-
Overall Score
4 / 5
High
DCF Score
4 / 5
High
ROE Score
4 / 5
High
ROA Score
5 / 5
High
D/E Score
3 / 5
Medium
P/E Score
2 / 5
Medium
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Healthcare Information Services: +14.2%-4.8% Q1'26: -24.9% (vs Q1'25)
-
EPS growth Medical - Healthcare Information Services: +43.1%+2.6% Q1'26: -86.4% (vs Q1'25)
-
FCF margin FCF growth · Medical - Healthcare Information Services: +49.2%+10.3% Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Medical - Healthcare Information Services: +8.8%+15.5% ★ Q1'26: +4.3% (vs Q1'25)
-
ROIC Medical - Healthcare Information Services: +5.2%+19.0% ★ Q1'26: +4.1% (vs Q1'25)
-
Share dilution Medical - Healthcare Information Services: -0.1%-1.4% ★ Q1'26: +0.2% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Healthcare Information Services: -0.74×0.12× ★ Q1'26: 0.37× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2014 actual |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
11.37B
est: 11.51B (-1.2%)
|
11.26B
est: 12.75B (-11.7%)
|
13.20B
est: 13.65B (-3.3%)
|
13.68B
est: 14.35B (-4.7%)
|
13.95B
est: 12.60B (+10.7%)
|
13.13B
est: 13.65B (-3.8%)
|
14.02B
est: 9.45B (+48.4%)
|
12.88B
est: 9.45B (+36.3%)
|
14.44B
est: 14.00B (+3.1%)
|
16.92B
est: 17.10B (-1.1%)
|
20.36B
est: 19.70B (+3.3%)
|
24.84B
est: 23.80B (+4.4%)
|
23.66B
est: 23.50B (+0.7%)
|
23.50B
23.50B – 23.50B
+0.0% YoY
|
24.60B
24.60B – 24.60B
+4.7% YoY
|
26.00B
26.00B – 26.00B
+5.7% YoY
|
| EBITDA |
2.42B
est: 2.60B (-6.8%)
|
1.96B
est: 2.88B (-31.8%)
|
2.64B
est: 3.08B (-14.5%)
|
3.27B
est: 3.24B (+0.8%)
|
3.66B
est: 2.85B (+28.6%)
|
3.17B
est: 3.08B (+2.8%)
|
2.81B
est: 2.13B (+31.5%)
|
2.29B
est: 2.13B (+7.5%)
|
2.85B
est: 3.16B (-10.0%)
|
3.37B
est: 3.86B (-12.8%)
|
3.79B
est: 4.15B (-8.6%)
|
6.03B
est: 5.82B (+3.6%)
|
4.97B
est: 5.75B (-13.5%)
|
5.75B
5.75B – 5.75B
+0.0% YoY
|
6.02B
6.02B – 6.02B
+4.7% YoY
|
6.36B
6.36B – 6.36B
+5.7% YoY
|
| EBIT |
1.67B
est: 1.90B (-12.1%)
|
1.23B
est: 2.11B (-41.5%)
|
1.86B
est: 2.26B (-17.5%)
|
2.60B
est: 2.37B (+9.5%)
|
3.06B
est: 2.08B (+47.1%)
|
2.62B
est: 2.26B (+16.3%)
|
—
est: 1.56B (-100.0%)
|
1.38B
est: 1.56B (-11.4%)
|
1.87B
est: 2.31B (-19.1%)
|
2.40B
est: 2.83B (-15.2%)
|
2.33B
est: 2.87B (-18.7%)
|
4.47B
est: 4.73B (-5.6%)
|
3.68B
est: 4.67B (-21.3%)
|
4.67B
4.67B – 4.67B
+0.0% YoY
|
4.89B
4.89B – 4.89B
+4.7% YoY
|
5.17B
5.17B – 5.17B
+5.7% YoY
|
| Net Income |
1.42B
est: 1.59B (-10.4%)
|
965.00M
est: 1.62B (-40.4%)
|
1.62B
est: 1.96B (-17.3%)
|
2.12B
est: 2.55B (-17.0%)
|
2.37B
est: 2.11B (+12.5%)
|
1.97B
est: 1.51B (+30.9%)
|
1.39B
est: 1.15B (+21.1%)
|
1.41B
est: 1.15B (+23.0%)
|
1.83B
est: 1.50B (+22.0%)
|
1.89B
est: 2.06B (-8.1%)
|
1.96B
est: 2.30B (-14.5%)
|
2.43B
est: 2.00B (+21.4%)
|
2.45B
est: 2.69B (-8.7%)
|
2.01B
2.01B – 2.01B
-25.3% YoY
|
2.30B
2.30B – 2.30B
+14.9% YoY
|
2.51B
2.51B – 2.51B
+8.7% YoY
|
| SGA |
4.40B
est: 1.14B (+284.5%)
|
4.79B
est: 1.27B (+277.8%)
|
4.84B
est: 1.36B (+256.4%)
|
4.76B
est: 1.43B (+233.7%)
|
4.48B
est: 1.25B (+257.4%)
|
4.53B
est: 1.36B (+233.9%)
|
494.00M
est: 939.88M (-47.4%)
|
5.01B
est: 939.88M (+433.1%)
|
5.02B
est: 1.39B (+260.3%)
|
5.69B
est: 1.70B (+234.6%)
|
7.28B
est: 3.23B (+125.0%)
|
8.69B
est: 8.19B (+6.1%)
|
7.78B
est: 8.08B (-3.8%)
|
8.08B
8.08B – 8.08B
+0.0% YoY
|
8.46B
8.46B – 8.46B
+4.7% YoY
|
8.95B
8.95B – 8.95B
+5.7% YoY
|
| EPS |
22.79
est: 22.33 (+2.1%)
|
14.95
est: 22.81 (-34.4%)
|
23.33
est: 27.60 (-15.5%)
|
30.15
est: 35.90 (-16.0%)
|
33.35
est: 29.65 (+12.5%)
|
27.86
est: 21.20 (+31.4%)
|
19.74
est: 16.20 (+21.9%)
|
19.92
est: 16.20 (+23.0%)
|
25.72
est: 21.10 (+21.9%)
|
26.74
est: 29.00 (-7.8%)
|
27.76
est: 32.60 (-14.8%)
|
34.54
est: 28.80 (+19.9%)
|
35.44
est: 38.70 (-8.4%)
|
28.90
28.90 – 28.90
-25.3% YoY
|
33.20
33.20 – 33.20
+14.9% YoY
|
36.10
36.10 – 36.10
+8.7% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-14 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-13 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-12 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-11 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-08 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-07 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 3/5 |
| 2026-05-01 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-04-30 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-04-28 | A | 4/5 | 4/5 | 4/5 | 5/5 | 3/5 | 3/5 | 3/5 |
| 2026-04-27 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-24 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-23 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-22 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-21 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-20 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-17 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-16 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-15 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-14 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
382.92M
OE per share TTM
5.46
Owner's Yield
1.02%
Maintenance CapEx ratio
0.29%
Maint CapEx / Avg PPE
7.8%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
4.45M
Shares Outstanding
69.22M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Daigo Kobayashi | Senior Executive Officer & Head of Corp Strategy HQ | — | — |
| Hirokazu Kawanohara | Executive Officer & GM of Integrated Quality Control HQ | — | male |
| Hiromasa Kunimitsu | President, Chief Executive Officer, Executive Officer & Representative Director | — | male |
| Kashihara | Executive - Corporate Strategy Department | — | — |
| Kenji Oishi | Executive Chairman | — | male |
| Koji Togawa | Executive Officer & Head of Medical Sales Division - Sales Headquarters | — | — |
| Kozo Kunimitsu | Chief Advisor & Director | — | male |
| Megumi Seki | Senior Executive Officer, GM of Management Headquarters & Director | — | female |
| Ryusuke Morita | Executive Officer, Head of Dispensing Company & Business Mgmt HQ | — | — |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 4820.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
